COMP <GO>
NVCR vs KMTS // FORWARD P/E MULTIPLE
NovoCure Limited (NASDAQ) VS. Kestra Medical Technologies Ltd. (NASDAQ) • 15-METRIC TALLY: NVCR 6
— KMTS 4
■ METRIC PARITY
LAST: $13.21 (+0.46%) • MKT CAP: $1.54B
forward-pe
—
LAST: $29.81 (+0.40%) • MKT CAP: $1.77B
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVCR VS. KMTS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NVCR | KMTS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.50% | 51.40% | +23.10 | NVCR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -27.50% | -35.00% | +7.50 | NVCR | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.96% | -6.40% | +1.44 | NVCR | /fcf-yield <GO> |
| Operating Margin | -23.50% | -60.00% | +36.50 | NVCR | /operating-margins <GO> |
| Net Profit Margin | -20.80% | -60.00% | +39.20 | NVCR | /net-margins <GO> |
| Revenue Growth (YoY) | 8.30% | 59.00% | -50.70 | KMTS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.54 | 9.65 | -9.11 | KMTS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 5/9 | +1.00 | NVCR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.3 | 56.2 | -21.90 | KMTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.54B | $1.77B | -$230.9M | KMTS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NVCR REV | KMTS REV | NVCR GROSS % | KMTS GROSS % | NVCR FCF | KMTS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $655.4M | $95.1M | 74.5% | 51.4% | -$75.7M | -$116.6M |
| FY 2024 | $605.2M | $59.8M | 77.3% | 40.5% | -$69.2M | -$100.5M |
| FY 2023 | $509.3M | $27.8M | — | — | -$73.3M | -$72.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVCR // BETA —
KMTS // BETA —